- Home
- / Plex Bio
Plex Bio
Stock Price
NT$12.6
2024-10-29
Market Capitalization
NT$1.3 B
2024-10-29
Revenue
NT$128.1 M
FY, 2024
Plex Bio Summary
Company Summary
- Overview
- Plex Bio is a company that designs, develops, and manufactures in vitro diagnostic products and instrumentations. It researches reagents focusing on companion diagnostics, early cancer detection, prenatal diagnostics, and food safety testing.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- TW | view all locations
- Website
- https://www.plexbio.com/
- Cybersecurity rating
Table of Contents
Key People
Lipi Yeh, Chief Financial Officer
Dean Tsao, Chairman & Chief Executive Officer
Clement Huang, Director, International Sales & Marketing - (APAC/ME)
LocationsView all
1 location detected
Taipei City HQ
Taiwan
Neihu District
Plex Bio Financials
Summary Financials
- Revenue (H1, 2025)
- NT$58.3M
- Gross profit (H1, 2025)
- NT$27.0M
- Net income (H1, 2025)
- (NT$43.6M)
- Cash (H1, 2025)
- NT$195.4M
- EBIT (H1, 2025)
- (NT$35.0M)
- Enterprise value
- $1.1B